Skip to content

Active ingredient

Febuxostat

45 finished FDA listings contain Febuxostat as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
FEBUXOSTAT
Dosage forms
Film, Tablet, Tablet, Coated, Tablet, Film Coated
Routes
Oral
Manufacturers / labelers
24
Strengths listed
40 mg/1 · 80 mg/1
Brand names in FDA listings
Febuxostat, Uloric

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 73689

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 021856TAKEDA PHARMS USA2009-02-132
ANDA 205421ALEMBIC2019-07-014
ANDA 205467SUN PHARM2019-07-016
ANDA 205414HIKMA2019-10-155
ANDA 210292REGCON HOLDINGS2019-12-302
ANDA 210461MSN2019-12-306
ANDA 213069SUNSHINE2020-06-024
ANDA 205374DR REDDYS2020-10-222
ANDA 212924ALKEM LABS LTD2021-12-072
ANDA 206266PRINSTON INC2022-03-282
ANDA 205443ZYDUS LIFESCIENCES2023-01-096
ANDA 207293MACLEODS PHARMS2023-09-282
ANDA 210741AUROBINDO PHARMA LTD2023-10-252

Official labeling on DailyMed

Showing the 12 most recent of 26 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.